SENZA.ST
Price:
$6.06
Market Cap:
$178.79M
SenzaGen AB develops, performs, and sells non-animal tests for assessing a substance's allergenicity. The company offers genomic allergen rapid detection (GARD)skin, an in vitro test to identify potential chemical skin sensitizers; GARDpotency, an in vitro add-on test to GARDskin for potency classification; GARDskin Dose-response, an in vitro test for quantitative skin sensitizing potency assessment of chemicals; and GARDair, an in vitro test for identifying chemical respiratory sensitizers, as well as GARDskin medical device, an in vitro skin sensitization testing for medical devices and solid materials. It also provides irritation and corrosion testing services. The company offers services...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2017-09-21
Stock Exchange
STO
Ticker
SENZA.ST
According to SenzaGen AB’s latest financial reports and current stock price. The company's current PE Ratio is -11.22. This represents a change of -6.96% compared to the average of -12.06 of the last 4 quarters.
The mean historical PE Ratio of SenzaGen AB over the last ten years is -33.83. The current -11.22 PE Ratio has changed 3.22% with respect to the historical average. Over the past ten years (40 quarters), SENZA.ST's PE Ratio was at its highest in in the December 2019 quarter at -2.22. The PE Ratio was at its lowest in in the September 2016 quarter at -62.20.
Average
-33.83
Median
-11.10
Minimum
-163.92
Maximum
-6.01
Discovering the peaks and valleys of SenzaGen AB PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 70.48%
Maximum Annual PE Ratio = -6.01
Minimum Annual Increase = -109.17%
Minimum Annual PE Ratio = -163.92
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -10.55 | 32.37% |
| 2023 | -7.97 | -31.60% |
| 2022 | -11.65 | 51.75% |
| 2021 | -7.68 | -25.05% |
| 2020 | -10.24 | 70.48% |
| 2019 | -6.01 | -81.60% |
| 2018 | -32.65 | -10.56% |
| 2017 | -36.50 | -28.57% |
| 2016 | -51.10 | -68.83% |
| 2015 | -163.92 | -109.17% |
The current PE Ratio of SenzaGen AB (SENZA.ST) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-10.06
5-year avg
-9.62
10-year avg
-33.83
SenzaGen AB’s PE Ratio is less than iZafe Group AB (publ) (-9.05), less than Clinical Laserthermia Systems AB (publ) (-4.75), less than Enorama Pharma AB (publ) (-2.22), less than Isofol Medical AB (publ) (-3.38), greater than Initiator Pharma A/S (-11.92), greater than Nosa Plugs AB (-16.06), less than Annexin Pharmaceuticals AB (publ) (-3.19), less than Integrum AB (publ) (-7.59), less than Bio-Works Technologies AB (publ) (-6.29), less than Q-linea AB (publ) (-0.78),
| Company | PE Ratio | Market cap |
|---|---|---|
| -9.05 | $139.14M | |
| -4.75 | $182.21M | |
| -2.22 | $170.06M | |
| -3.38 | $196.78M | |
| -11.92 | $201.25M | |
| -16.06 | $153.24M | |
| -3.19 | $134.83M | |
| -7.59 | $223.41M | |
| -6.29 | $184.13M | |
| -0.78 | $137.58M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SenzaGen AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SenzaGen AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is SenzaGen AB's PE Ratio?
How is the PE Ratio calculated for SenzaGen AB (SENZA.ST)?
What is the highest PE Ratio for SenzaGen AB (SENZA.ST)?
What is the 3-year average PE Ratio for SenzaGen AB (SENZA.ST)?
What is the 5-year average PE Ratio for SenzaGen AB (SENZA.ST)?
How does the current PE Ratio for SenzaGen AB (SENZA.ST) compare to its historical average?